North America Defibrillators Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Defibrillators Market Size

• The North America defibrillators market size was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.17 billion by 2032, exhibiting a CAGR of 5.3% during the forecast period of 2025-2032.
• Furthermore, the increasing incidence of cardiovascular diseases, including sudden cardiac arrest, is emphasizing the critical role of defibrillators in emergency response and patient management.
• These converging factors are driving the adoption of defibrillators across various settings, thereby significantly propelling the industry's growth in the region.

Defibrillators Market Analysis

• Defibrillators, which deliver controlled electrical shocks to restore normal heart rhythm, are increasingly essential medical devices in hospitals, emergency medical services, and public spaces due to their life-saving capabilities during cardiac emergencies.
• The growing demand for defibrillators is primarily driven by the rising prevalence of heart conditions, increasing awareness about the importance of early defibrillation, and technological advancements leading to more user-friendly and effective devices.
•  The U.S. commands the largest revenue share in the North America defibrillators market, accounting for 58.27% in 2024 owing to its advanced healthcare infrastructure, high healthcare spending, and the strong presence of leading medical device manufacturers.
• The automated external defibrillators (AEDs) segment is expected to dominate the North America defibrillators market with a share of 45.78% in 2025, driven by their ease of use and increasing deployment in public access locations.

Report Scope and Defibrillators Market Segmentation

Defibrillators Market Trends

“Growing Emphasis on Public Access Defibrillation (PAD) Programs”

• A significant trend in the North America defibrillators market is the increasing implementation and expansion of public access defibrillation (PAD) programs. These initiatives aim to make AEDs readily available in public places such as airports, schools, shopping malls, and workplaces to improve survival rates from sudden cardiac arrest.

• For instance, many states and local governments are enacting legislation and providing funding to support the deployment of AEDs in public areas and to train individuals in their use.

• Furthermore, advancements in AED technology, including improved ease of use and voice prompts, are making them more accessible to lay responders, further supporting the growth of PAD programs
• The integration of mobile health (mHealth) applications with AED devices to alert trained responders to nearby cardiac emergencies is also enhancing the effectiveness of PAD initiatives.

Defibrillators Market Dynamics

Driver

“Rising Incidence of Cardiovascular Diseases and Sudden Cardiac Arrest”

• The increasing prevalence of cardiovascular diseases, a leading cause of mortality in North America, is a primary driver for the heightened demand for defibrillators. Sudden cardiac arrest (SCA), often resulting from underlying heart conditions, necessitates immediate defibrillation for survival.

• For instance, the aging population, coupled with lifestyle factors contributing to heart disease such as obesity and lack of physical activity, is leading to a higher incidence of cardiac events.

• As the risk of SCA rises, the need for effective and readily available defibrillation devices in both clinical and public settings becomes increasingly critical.
• Furthermore, growing awareness among the general public and healthcare professionals about the importance of early intervention in cardiac emergencies is contributing to increased adoption of defibrillators.

Restraint/Challenge

“High Cost of Implantable Defibrillators and Reimbursement Challenges”

• The substantial cost of implantable cardioverter-defibrillators (ICDs) and the associated implantation procedures can present a significant barrier to market growth, particularly for patients with limited insurance coverage or in healthcare systems facing budget constraints.

• For instance, the complexity of ICD devices and the specialized surgical expertise required for implantation contribute to their high cost, potentially limiting their accessibility to all eligible patients.

• Additionally, variations in reimbursement policies across different insurance providers and regions in North America can create uncertainties and delays in patient access to these life-saving devices.
• Addressing these cost and reimbursement challenges through value-based care models, cost-effectiveness analyses, and clear reimbursement guidelines will be crucial for ensuring broader patient access to ICD therapy.
• While efforts are underway to improve affordability and streamline reimbursement processes, these issues remain significant considerations for market expansion.

Defibrillators Market Scope

The market is segmented based on type and end-user.

By Type

On the basis of type, the North America defibrillators market can be segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators (manual external defibrillators, automated external defibrillators (AEDs)). The automated external defibrillators (AEDs) segment dominates the largest market revenue share of 45.78% in 2024 due to increasing public awareness and accessibility.

The implantable cardioverter defibrillators (ICDs) segment is anticipated to witness the fastest growth rate of 11.7% from 2025 to 2032. due to the rising prevalence of life-threatening arrhythmias and sudden cardiac arrest. The growing emphasis on long-term cardiac monitoring and prevention is driving ICD adoption in high-risk patient populations.

By End-user

On the basis of end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers, home care settings, and public access settings. The hospitals segment accounted for the largest market revenue share in 2024 due to the concentration of critical care and cardiac procedures. 

However, the public access settings segment is gaining rapid traction due to increasing initiatives to make defibrillators widely available in public spaces for emergency use. Rising awareness about sudden cardiac arrest and the critical importance of immediate intervention are driving deployments in airports, malls, schools, and sports venues. Technological advancements have led to user-friendly, automated external defibrillators (AEDs) designed for use by untrained bystanders.

Defibrillators Market Regional Analysis

• The U.S. dominates the North America defibrillators market with the largest revenue share of 58.27% in 2024, driven by a high prevalence of cardiovascular diseases, well-established emergency medical services, and favorable reimbursement policies for medical devices
• This significant market share is also supported by the presence of major medical device manufacturers and continuous technological advancements in defibrillator technology.

U.S. Defibrillators Market Insight

The U.S. defibrillators market captured the largest revenue share of 58.27% within North America in 2024, fueled by a large and aging population, high rates of cardiac diseases, and strong adoption of advanced medical technologies. The increasing focus on improving survival rates from sudden cardiac arrest and the widespread implementation of PAD programs further contribute to market growth.

Canada Defibrillators Market Insight

The Canada Defibrillators Market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by a growing geriatric population and increasing government initiatives to improve cardiac care. The rising awareness about the importance of early defibrillation and investments in healthcare infrastructure are supporting market expansion.

Mexico Defibrillators Market Insight

The Mexico Defibrillators Market is expected to expand at a considerable CAGR during the forecast period, due to increasing healthcare expenditure and a growing awareness of advanced cardiac care solutions. The rising incidence of cardiovascular diseases and efforts to improve emergency response capabilities are driving demand for defibrillators.

Defibrillators Market Share

The Defibrillators industry is primarily led by well-established companies, including:

• Medtronic (U.S.)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• Philips (Netherlands)
• ZOLL Medical Corporation (U.S.)
• Cardiac Science Corporation (U.S.)
• Nihon Kohden Corporation (Japan)
• Physio-Control, Inc. (U.S.)
• Defibtech, LLC (U.S.)
• HeartSine Technologies (U.K.)

Latest Developments in North America Defibrillators Market

• In April 2025, BD launched next-generation wearable defibrillators for at-home use in high-risk cardiac patients not eligible for implantable devices. These devices provide continuous monitoring and automatic therapy for life-threatening arrhythmias, enhancing early intervention, expanding treatment options, and potentially improving outcomes for patients at risk of sudden cardiac arrest.

SKU-1797